EUVIMEDEUVIMED entdecken
Open Access

The ratio of lymphocyte/red blood cells and platelets/lymphocytes are predictive biomarkers for lymph node metastasis in patients with breast cancer

Haofeng Wang, Jinling Yu, Weida Shen, Haiyan Zhao, Jing Cui, Beimin Gao

Cancer Biomarkers · 2023

DOI: 10.3233/cbm-220260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, 2023. Verfasst von Haofeng Wang und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Axillary lymph node metastasis (LNM) affects the progression of breast cancer. However, it is difficult to preoperatively diagnose axillary lymph node status with high sensitivity. Therefore, we hypothesized that platelets/lymphocytes ratio (PLR) and lymphocytes/ red blood cells ratio (LRR) might help in the prognosis of lymph node metastasis in T1-T2 breast cancer. METHODS: 166 patients (Chang Ning Maternity & Infant Health Institute) were included in our study, and the associations of PLR and LPR with lymph node metastasis were investigated. Peripheral blood was collected one week before the surgery, and the patients were divided into different categories based on their PLR and LRR. RESULTS: The incidence of LNM was significantly increased in the high PLR group (p= 0.002) compared with the low PLR group; LNM was also significantly increased in the low LRR group (p= 0.036) compared with the high LPR group. Further, our study revealed that high PLR (p< 0.001, OR = 4.397, 95% CI = 2.005–9.645), low LRR (p= 0.017, OR = 0.336, 95%CI = 0.136–0.825) and high clinical T stage (p< 0.001, OR = 3.929, 95%CI = 1.913–8.071) are independent predictors of LNM. CONCLUSIONS: PLR and LRR could be identified as predictors of LNM in patients with T1/T2 breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPregnancyHumansFemaleLymphatic MetastasisNeutrophilsLymphocytesBlood PlateletsBiomarkersPrognosisErythrocytesRetrospective Studies

Stichwörter der Autor:innen

Breast cancerbiomarkerlymphocytesplateletred blood cell

Substanzen

Biomarkers

Zitieren

APA

Wang, H., Yu, J., Shen, W., Zhao, H., Cui, J., & Gao, B. (2023). The ratio of lymphocyte/red blood cells and platelets/lymphocytes are predictive biomarkers for lymph node metastasis in patients with breast cancer. Cancer Biomarkers. https://doi.org/10.3233/cbm-220260

Vancouver

Wang H, Yu J, Shen W, Zhao H, Cui J, Gao B. The ratio of lymphocyte/red blood cells and platelets/lymphocytes are predictive biomarkers for lymph node metastasis in patients with breast cancer. Cancer Biomarkers. 2023. doi:10.3233/cbm-220260

BibTeX
@article{Wang2023,
  author = {Wang, Haofeng and Yu, Jinling and Shen, Weida and Zhao, Haiyan and Cui, Jing and Gao, Beimin},
  title = {The ratio of lymphocyte/red blood cells and platelets/lymphocytes are predictive biomarkers for lymph node metastasis in patients with breast cancer},
  journal = {Cancer Biomarkers},
  year = {2023},
  doi = {10.3233/cbm-220260}
}
Kostenlos starten →